Surfacide, LLC

Surfacide, LLC, a for-profit limited liability company and small-business manufacturer headquartered in Waukesha, Wisconsin, supplies UV-C surface disinfection and room sterilization equipment to the Department of Veterans Affairs as a prime contractor, operating exclusively on full-and-open and total small business set-aside awards with no subcontract footprint. The vendor manufactures FDA Class II cleared whole-room microbial reduction systems under proprietary brand names including Helios, Helios+, and SurfCare, with equipment engineered for 254-nanometer UV-C wavelength capability and motion-sensor safety features; work is performed in Vernon, Wisconsin.

Surfacide's customer concentration is almost entirely within the Veterans Health Administration. The Department of Veterans Affairs Veterans Integrated Service Network 8, 10, 16, 19, and 22 account for 88% of awards by count and 93% by combined potential value, with VISN 8 and VISN 10 each anchoring roughly $1.3 to $1.5 million in recent potential value. The vendor holds a seat on the GSA Multiple Award Schedule (MAS) issued January 15, 2023, running through January 14, 2028, with a $500,000 ceiling; four task orders under MAS carry combined potential value exceeding $920,000. Surfacide also holds a single-award indefinite-delivery contract with VISN 10 issued September 14, 2026, for $615,920, covering Helios and SurfCare equipment and maintenance services through August 31, 2031.

Recent representative work includes a $874,000 sole-source purchase order from VISN 8 awarded August 27, 2026, for eight Helios UV-C whole-room disinfection systems (ultimate completion November 4, 2026), a $615,920 total small business IDIQ with VISN 10 awarded September 14, 2026, for four Helios+ Triple Emitter Systems with four years of annual SurfCare Premium service coverage (ultimate completion August 31, 2031), a $408,000 total small business delivery order from VISN 10 awarded September 14, 2026, for Surfacide Helios and SurfCare products (ultimate completion September 13, 2027), and a $370,965 total small business purchase order from VISN 22 awarded September 18, 2026, for mobile UV disinfection devices including FDA-cleared Class II whole-room microbial reduction equipment (ultimate completion November 30, 2026). Historical maintenance and service contracts span multiple VISN locations, including $272,895 in warranty and maintenance for SurfCare Triple Emitter Systems at the C.W. Bill Young VA Medical Center in Bay Pines, Florida (awarded February 1, 2026, running through January 31, 2029).

Activity accelerated sharply in 2026: one award each in 2022, 2023, 2024, and 2025 versus twelve awards to date in 2026. Combined potential value across all sixteen prime awards stands at $4.6 million, with $3.2 million obligated (69% of potential). Seven awards carry ultimate completion dates within the next twenty-four months and represent $2.3 million in recompete exposure. Procurement is split between sole-source awards (where Surfacide's FDA 510(k)-cleared continuous UV-C technology is determined unique for VA clinical environments with photosensitive patients) and total small business set-aside orders, with no full-and-open competitive awards in the recent portfolio. Top NAICS categories are HVAC equipment manufacturing (seven awards) and medical/surgical appliances (three awards); top PSC codes center on medical and surgical instruments and hospital equipment supplies.

Surfacide provides an evidence-based, automated UV-C system that data indicate is effective against multi-drug resistant organisms including C.diff, MRSA, VRE, CRE and Acinetobacter. Our approach is different. The Surfacide Helios system utilizes multiple emitters to provide UV-C energy to more exposed areas with more power and efficacy as compared to single emitter systems.